Connect with us

Emerging Markets

Rushnet Inc (OTCMKTS: RSHN) Major Runner as heliosDX Launches 6 Part Interview Series Airing on National TV

Published

on

Rushnet Inc (OTCMKTS: RSHN) is racing up the charts after the Company announced it and its recently acquired subsidiary heliosDX will conduct a 6 Part interview series to be conducted by FMW Media’s New to The Street/ Newsmax that will be carried by a number of nationwide media outlets including Fox Business, Bloomberg Network, Newsmax, KRON, RNN, and potentially other outlets. The reach of these networks is in excess of over 300 million homes. RSHN is under heavy accumulation and volume has picked up substantially as the stock looks to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension; a break over $0.0249 and its blue skies ahead. 

RushNet, Inc recently acquired heliosDX, a National Diagnostics Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. heliosDX is contracted in 44 of the lower 48 states and looking to expand its reach and capabilities. hiliosDX is CLIA Certified, HIPAA compliant and was recently recognized by COLA for its laboratory excellence. heliosDX is currently doing around $1.5 million in revenues per quarter and is on track to do $5 to $6 million in revenues in 2021. heliosDX being acquired by RushNet was the first milestone for heliosDX realizing its goal to becoming a fully reporting standalone company trading under its own symbol. The company is currently preparing its applications for FINRA, SEC and disclosures. The timing of the interviews could not have come at a more perfect time for heliosDX as the Company prepares to launch a National Sales Campaign utilizing Verb Technology Company cutting edge interactive sales and marketing platform (verbTEAMS and verbLIVE).  

Rushnet Inc (OTCMKTS: RSHN) has been operating as a edible and beverage-based company which recently acquired heliosDX; a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. heliosDX is contracted in 44 of the lower 48 states and looking to expand its reach and capabilities. Always staying ahead of the curve, by continually investing in its infrastructure with the most efficient scientific proven instruments, and latest cutting-edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. The Company excels in patient and client care through physician designed panels that aid in testing compliance and reporting education. heliosDX as the first step to bring value to shareholders. The has company progressed in the last few months and plans future acquisitions to bolster company and shareholder value. 

Q2 was another record quarter for heliosDX. In the 1st Quarter of 2021, heliosDX generated a record $1,252,000 in revenue. This was a new company benchmark. In April and May 2021, heliosDX has generated revenues totaling approximately $990,000 respectively. This is an average of $495,000 a month. This also includes another record of approximately $530,000 in revenue for the month of May. This growth puts heliosdDX on pace to hit their stretch projected 2nd quarter target of $1.4 to $1.5 million. This again sets another company benchmark. This would equate to just over a 20% revenue growth quarter over quarter. heliosDX enjoyed a 70%+ revenue growth from 2019 to 2020, and to see the growth continue speaks volumes to the execution of the plan, and the staff at heliosDX. 

For the Inside Scoop on Rushnet Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

RSHN

Microcapdaily has been reporting on RSHN for years starting in October 2018 stating at the time: “Rushnet Inc (OTCMKTS: RSHN) has been on the rise again in recent days; the stock is a volume leader with a long history of big moves running from triple zeros to highs of $0.008 earlier this year. Rushnet has attracted a large shareholder base who continues to bid this one higher. RSHN is at the right place at the right time; the cannabidiol (CBD) market is expected to hit $591 million this year, and it may grow 40 times this size—to $22 billion by 2022 – meaning that hemp-derived CBD could outpace all other cannabis markets, according to a new report by Brightfield Group. 

heliosDX previously announced there will be a dividend of 1 share of heliosDX for every 800 shares of RushNet owned upon close of the ex-dividend date. RushNet shareholders have access to purchase 11 additional shares of heliosDX per 1,000 shares of Rushnet, Inc at a 50% to market upon the close on the ex-dividend date. For every 10 shares purchased at the discount to market of 50% the shareholder receives one additional share of heliosDX. heliosDX will also include the ability to convert qualified shares of Rushnet into heliosDX upon the split-off. A qualified share of RushNet is a share owned on the close of the ex-dividend date. The conversion ratio is yet to be determine but is customarily done at an equal value with an incentive percentage to convert. The incentive percentage has not been determined but will not be less than 10%. 

We have a Monster Pick Coming. Subscribe Right Now!

RSHN is racing up the charts after the Company announced it and its recently acquired subsidiary heliosDX will conduct a 6 Part interview series to be conducted by FMW Media’s New to The Street/ Newsmax that will be carried by a number of nationwide media outlets including Fox Business, Bloomberg Network, Newsmax, KRON, RNN, and potentially other outlets. The reach of these networks is in excess of over 300 million homes. RushNet, Inc recently acquired heliosDX, a National Diagnostics Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. heliosDX is contracted in 44 of the lower 48 states and looking to expand its reach and capabilities. hiliosDX is CLIA Certified, HIPAA compliant and was recently recognized by COLA for its laboratory excellence. heliosDX is currently doing around $1.5 million in revenues per quarter and is on track to do $5 to $6 million in revenues in 2021. heliosDX being acquired by RushNet was the first milestone for heliosDX realizing its goal to becoming a fully reporting standalone company trading under its own symbol. The company is currently preparing its applications for FINRA, SEC and disclosures. The timing of the interviews could not have come at a more perfect time for heliosDX as the Company prepares to launch a National Sales Campaign utilizing Verb Technology Company cutting edge interactive sales and marketing platform (verbTEAMS and verbLIVE). RSHN is under heavy accumulation and volume has picked up substantially as the stock looks to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension; a break over $0.0249 and its blue skies ahead. We will be updating on RSHN when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with RSHN.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in RSHN either long or short and we have not been compensated for this article.

Continue Reading
1 Comment

1 Comment

  1. Investor's Center

    July 26, 2021 at 5:49 pm

    OTCM ticker of the year! Don’t hesitate to get in on this now before it’s over a dollar. From there it’s uplisting to the NASDAQ and the sky’s the limit. Early warning system on full alert.

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

on

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Emerging Markets

Chinese Nasdaq listings the next meme stock rally?

Published

on

Small and micro-cap Chinese companies listed in the U.S. are experiencing a surge in share prices, similar to the 2020 meme rallies during COVID.

Small and micro-cap Chinese companies listed in the U.S. are experiencing a surge in share prices, similar to the 2020 meme rallies during COVID. These rallies appear driven by social media sites used by individual traders and financial influencers.

To Find out the inside Scoop, subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Online brokerage firm Top Financial Group $TOP stock rose by nearly 4000% from $6.90 to $250 per share, while Magic Empire Global $MEGL stock jumped over 400% to $4.56 per share. 

Both stocks are now popular among retail investors on Stocktwits, Twitter, Discord, Reddit – you name it. Two other companies, Top KingWin $TCJH and U Power $UCAR, also saw their shares rise by 130% and 105%, respectively.

Thoughts from retail traders

With $TOP and $MEGL being the talk of the town, it’s safe to say that they have gained massive popularity online. Their growth and buzz are reminiscent of $AMC and $BB during their respective rallies in previous years. Some of the largest traders with over 1M followings have these stocks on their radar.

What does the NASDAQ have to say?

The NASDAQ regulatory body has a history of caution toward these kinds of investments. In October 2022, they stopped preparations for over four other micro-cap Chinese IPOs due to short-lived rallies following their debuts. Furthermore, U.S. exchanges and FINRA have issued warnings regarding the increased likelihood of fraud, especially in the IPOs of small companies, which are often influenced by social media-driven pump-and-dump schemes like the infamous “pig butchering” tactic.

Chinese Macro backdrop

While there was a significant sell-off just two weeks ago when China implemented stricter regulations regarding generative AI systems like ChatGPT, Chinese stocks are again on the rise. This is primarily due to the positive earnings forecast of electric car giant BYD and Chinese banks, which has sparked optimism in the market. The volatility of Hong Kong stocks over the past year far surpasses the meme stock frenzy of 2021, and savvy traders who can accurately time the market and make sound exit decisions are reaping significant profits. However, this requires long hours of tracking trends and charts, and those not up for the challenge risk losing everything by the following day.

We will update our subscribers when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with China meme stocks.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leslin_Liu from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.